Calibrate Weight Loss Reviews 2026: Cost, Results & Verdict

Calibrate's model is straightforward. You pay a monthly program fee. The company pairs you with a licensed clinician who prescribes a GLP-1 medication, typically semaglutide (Wegovy/Ozempic) or tirzepatide (Zepbound/Mounjaro). Medication ships through your insurance plan, not through Calibrate's pharmacy.

On top of the prescription, you receive biweekly video coaching sessions, access to a curriculum covering four "metabolic pillars" (food, exercise, sleep, emotional health), and a connected smart scale with app tracking.

The program runs 12 months. After the year ends, members can continue on a maintenance plan or transition medication management to their primary care physician.

Step-by-step enrollment process:

1. 1.Online eligibility quiz (free, takes 3 minutes)
2. 2.Lab work and metabolic assessment ($249, or covered by some insurance plans)
3. 3.Video consultation with a Calibrate clinician
4. 4.GLP-1 prescription sent to pharmacy (insurance billed directly)
5. 5.Smart scale shipped, app activated
6. 6.Biweekly video coaching sessions begin
7. 7.Monthly check-ins with medical team

The GLP-1 medications Calibrate prescribes are FDA-approved brand-name drugs. This distinguishes Calibrate from many telehealth competitors that prescribe compounded versions. Compounded semaglutide and compounded tirzepatide are not FDA-approved and differ in formulation from the branded products. Calibrate's reliance on brand-name medications means stronger clinical evidence behind the prescriptions but also means insurance is essential to keep costs manageable. For more on how semaglutide works and standard dosing, see our semaglutide dosage chart.

The $199 per month program fee is the number Calibrate leads with, but it does not include medication. Total out-of-pocket depends heavily on your insurance plan.

Total annual cost with good insurance: roughly $2,700 to $3,100 (program fee + medication copays + labs).

Total annual cost without GLP-1 insurance coverage: $12,000 to $20,000+ (program fee + cash-pay medication).

This price structure works if your insurance covers GLP-1 medications. If it does not, the total cost becomes prohibitive compared to alternatives. Calibrate does employ a team that navigates insurance authorization on your behalf, and the company states that most members with commercial insurance pay $25 per month or less for medication after deductible.

For context, compounded semaglutide through direct-to-consumer telehealth platforms like MEDVi runs $299 per month with no insurance required. Compounded tirzepatide starts around $349 to $399 per month at most platforms. Use our peptide cost calculator to compare options side by side.

HSA and FSA funds are accepted for the program fee. Calibrate does not offer its own financing beyond the monthly payment plan through Affirm.

Calibrate publishes an annual Results Report, now in its fourth year. The numbers, validated by the Validation Institute in March 2024, show consistent weight loss across the member base.

A 16% average at 12 months is clinically meaningful. For a 250-pound person, that translates to 40 pounds. The number aligns with what clinical trials show for semaglutide (the STEP trials demonstrated 15 to 17% weight loss with Wegovy) and falls within the range for tirzepatide (the SURMOUNT trials showed 18 to 22.5% with Zepbound).

The fact that weight loss increases from 16% at year one to 19% at year three is notable. Many GLP-1 studies show weight regain after medication discontinuation. Calibrate attributes the sustained trajectory to the behavioral component: members who internalize the food, exercise, sleep, and emotional health curriculum may maintain habits that prevent rebound.

Important caveat: these are self-reported outcomes from active members. People who dropped out, canceled in frustration, or never received medication are not represented in the 19% figure. The data describes what happens when the program works as intended, not the average experience across everyone who enrolls.

The company offers a 10% weight loss guarantee: if you do not lose at least 10% of your body weight after 12 consecutive months on the program, you are eligible for a 50% refund. The guarantee has conditions, so read the terms before assuming it applies to your situation. For comparison guidance on semaglutide before and after results across different timelines, see our dedicated analysis.

Calibrate's Trustpilot page is rated "Excellent" with a 4.6 out of 5. The majority of reviews are four and five stars, with members praising three areas consistently.

Coaching quality. The biweekly video sessions receive the most positive mentions. Members describe coaches who are knowledgeable, accountable, and genuinely engaged. Several reviews cite the coaching as the reason they stayed on track when motivation dropped.

Real weight loss. Many five-star reviews report 30 to 80+ pound losses within the first year. Timelines vary, but the pattern is consistent: meaningful weight loss begins within 4 to 8 weeks of starting medication and accelerates over months 3 through 6.

Insurance navigation. Members with commercial insurance frequently mention that Calibrate's team handled the prior authorization process and got their medication approved when their own doctor could not. This is a legitimate value-add for patients whose insurers are resistant to covering GLP-1 medications for weight loss.

Negative Trustpilot reviews focus on the same issues that dominate every other review platform:

1. 1.Medication access delays (prior authorization denied, pharmacy issues, multi-week gaps between refills)
2. 2.Customer service responsiveness (slow email responses, chatbot-heavy support, no phone line)
3. 3.Billing inflexibility (difficulty pausing or canceling when medication is unavailable)
4. 4.Provider turnover (assigned clinicians changing without notice)

The 4.6 rating reflects genuine satisfaction from the majority. But Trustpilot's review solicitation model tends to oversample satisfied customers. The BBB profile offers the other side of the story.

Calibrate Health, Inc. is not accredited by the Better Business Bureau and holds an F rating. The BBB customer review average is 1.23 out of 5 across 26 reviews. The complaint volume has increased markedly since 2022.

The F rating does not mean Calibrate is a scam. BBB ratings factor in complaint volume relative to company size, response patterns, and accreditation status. Companies that do not pay for BBB accreditation start at a disadvantage.

That said, the complaint patterns are consistent and worth examining.

Medication delays. This is the single largest complaint category. Members report paying the program fee, completing their consultation, receiving a prescription, and then waiting weeks or months for their insurance to approve the medication. During this waiting period, the program fee continues to be charged. Some members report waiting three weeks with no medication. Others describe six-month delays before receiving their first shipment.

Cancellation difficulties. Members who want to cancel describe a process that requires contacting customer support, receiving no response, and continuing to be billed. There is no self-service cancellation button in the app or on the website. Complaints describe multiple emails sent with no resolution.

Billing after cancellation requests. A subset of cancellation complaints involve members who submitted cancellation requests, received confirmation, and then saw additional charges on their credit card statements in subsequent months.

Communication gaps. Members describe all questions being routed through a support center that "rarely accomplishes anything." Direct access to the prescribing clinician is limited to scheduled appointments. Urgent medication questions (supply running out, side effects, dosage adjustments) go through the same general support channel.

The Reddit community r/calibrateweightloss echoes these patterns. Posts describe being ghosted by coaches, unable to reach support staff, and left without medication for extended periods. Not every member experiences these problems, but they are not isolated incidents.

If you are considering Calibrate, the practical takeaway is this: the program works well when insurance cooperates and medication flows without interruption. When either of those breaks down, you are dealing with a customer service system that many members describe as inadequate. For patients who want to get semaglutide with fewer intermediaries, working directly with your doctor or a simpler telehealth platform may reduce these friction points.

Calibrate prescribes FDA-approved, brand-name GLP-1 medications. The two primary options are semaglutide (marketed as Wegovy for weight loss) and tirzepatide (marketed as Zepbound for weight loss).

Most Calibrate members are prescribed semaglutide or tirzepatide, as these deliver the strongest weight loss outcomes. Liraglutide and dulaglutide are options when insurance denies the primary choices or the patient has contraindications.

The prescribing clinician determines which medication to start with based on your metabolic assessment, insurance formulary, and medical history. Titration follows standard FDA-approved dosing schedules: semaglutide starts at 0.25mg weekly and increases to 2.4mg over 16 to 20 weeks. Tirzepatide starts at 2.5mg weekly and increases to 15mg over a similar timeline. See our semaglutide dosage calculator and tirzepatide dosage calculator for step-by-step titration guides.

Because Calibrate uses brand-name medications filled through commercial pharmacies, the supply chain is more stable than compounded alternatives. However, brand-name GLP-1 shortages have affected the entire market. During the 2023-2024 shortage period, even insured patients experienced multi-week gaps in supply. The situation has improved in 2026, but sporadic availability issues persist at some pharmacies.

For a breakdown of how much semaglutide costs across different channels (insurance, cash-pay, compounded), see our pricing guide.

Calibrate's behavioral program is structured around four categories the company calls its "metabolic pillars." Each pillar has a defined curriculum delivered through the app and reinforced in coaching sessions.

Pillar 1: Food. The nutrition framework emphasizes protein intake, fiber, meal timing, and reducing ultra-processed foods. There is no calorie counting requirement. The coaching focuses on building sustainable eating patterns that complement the appetite suppression from GLP-1 medication. Members receive meal planning guidance and recipes through the app.

Pillar 2: Exercise. The exercise protocol starts modest: 15 to 30 minutes of movement daily, with emphasis on consistency over intensity. As weight loss progresses, coaching adjusts to include resistance training for lean mass preservation. This is relevant because GLP-1 medications can cause muscle loss alongside fat loss. For patients concerned about this, our analysis of best peptides for weight loss covers adjunct options for body composition.

Pillar 3: Sleep. Calibrate's curriculum includes sleep hygiene protocols: consistent bedtime, screen reduction, temperature optimization. The connection to weight loss is supported by research showing that poor sleep increases ghrelin (hunger hormone) and impairs insulin sensitivity. The smart scale tracks sleep patterns when paired with compatible devices.

Pillar 4: Emotional Health. The emotional health component addresses stress management, emotional eating triggers, and the psychological aspects of weight loss. Coaching sessions explore patterns that lead to overeating and build alternative coping strategies.

The four-pillar structure is the primary differentiator between Calibrate and platforms that simply prescribe medication. A prescription alone produces weight loss, but the behavioral framework aims to sustain results after medication ends. The clinical question is whether behavioral coaching during GLP-1 treatment actually prevents regain. Calibrate's 36-month data (19% average loss) suggests it helps, though we lack a control group of medication-only patients for direct comparison.

The GLP-1 telehealth landscape has expanded significantly. Calibrate occupies the premium, insurance-first tier. Here is how it compares to the primary alternatives.

Calibrate wins on: clinical evidence (brand-name medications), structured behavioral coaching, insurance navigation, sustained long-term results data.

Calibrate loses on: total cost for patients without good insurance, customer service responsiveness, cancellation flexibility, speed of medication access.

The insurance divide. If your employer plan covers Wegovy or Zepbound with a reasonable copay, Calibrate's total cost ($199/month program + $25/month medication) is actually cheaper than most compounded alternatives at $299 to $399 per month. If your insurance does not cover GLP-1 medications, Calibrate becomes the most expensive option by a wide margin.

Brand-name vs. compounded. Calibrate prescribes FDA-approved medications backed by large-scale Phase III trials. Platforms like MEDVi and Ellie MD prescribe compounded versions that are not FDA-approved and differ in formulation. Both produce weight loss, but the evidence base is stronger for brand-name products. For more on whether compounded formulations are equivalent, see our compound tirzepatide safety analysis.

Coaching depth. Calibrate's biweekly video coaching is more intensive than what most telehealth competitors offer. MEDVi provides 24/7 provider messaging but not scheduled video sessions. Willow includes metabolic coaching. Most others provide minimal or no behavioral support beyond the prescription.

Patients who plateau on medication may benefit from Calibrate's coaching structure. For those already not losing weight on semaglutide, the behavioral intervention could address underlying factors that medication alone does not fix.

Calibrate is a strong fit if you:

• Have commercial insurance that covers Wegovy or Zepbound (check your formulary first)
• Want FDA-approved, brand-name GLP-1 medication rather than compounded alternatives
• Value structured behavioral coaching alongside medication
• Are committed to a 12-month program and willing to pay $199 per month for the platform
• Have struggled with weight loss previously and need accountability beyond a prescription
• Prefer a Validation Institute-certified program with published outcomes data

Calibrate is not recommended if you:

• Do not have insurance coverage for GLP-1 medications (total cost becomes $12,000+ annually)
• Need immediate medication access (insurance authorization can take weeks)
• Want easy, self-service cancellation with no friction
• Prioritize responsive customer support (BBB complaint patterns are persistent)
• Prefer a simpler transaction: prescription and medication with minimal overhead
• Are looking for the lowest possible cost (ivim Health starts around $150 per month all-in)

The decision framework is simple. Call your insurance company. Ask whether Wegovy (semaglutide) or Zepbound (tirzepatide) is covered under your plan and what the copay would be after deductible. If the answer is yes with a reasonable copay, Calibrate's total cost is competitive and you get a structured program on top. If the answer is no, look at compounded alternatives through MEDVi or Ellie MD, or ask your primary care physician about prescribing directly.

Before you enroll, ask these five questions:

1. 1.Does my insurance cover Wegovy or Zepbound? (Call the number on your insurance card, ask about the formulary)
2. 2.What is the prior authorization timeline? (Some plans approve in days; others take weeks)
3. 3.What is my copay after deductible? (Under $50/month makes Calibrate viable; over $200/month does not)
4. 4.What is Calibrate's current cancellation policy? (Get it in writing before entering payment information)
5. 5.Am I comfortable with a 12-month commitment at $199/month with no self-service cancellation?

If the answers to questions 1 through 3 are favorable and you are comfortable with 4 and 5, Calibrate becomes a genuinely strong option. The coaching, smart scale integration, and published outcomes data set it apart from simpler telehealth prescription services. Use our semaglutide dosage calculator to understand standard titration before your first consultation.

No program review is complete without an honest assessment of the risks. Calibrate is a legitimate company backed by major venture capital firms, prescribing real FDA-approved medications through licensed clinicians. It is not a scam. But several factors warrant caution.

The BBB F rating is real. An F rating from the BBB, combined with a 1.23 out of 5 customer review average, signals systemic customer service failures. Companies that treat their customers well do not accumulate this pattern regardless of whether they pay for BBB accreditation.

Leadership turnover. Founder and original CEO Isabelle Kenyon stepped down in October 2023. The company went through a leadership transition and what investors described as "rapid downsizing" of the consumer business. Leadership instability at a company managing your medication and health coaching is a legitimate concern.

The 50% refund guarantee is not a full refund. If you do not lose 10% of your body weight in 12 months, you get 50% of your program fee back. Not 100%. And the conditions for eligibility (consecutive months on program, compliance with coaching schedule) may disqualify members who experienced medication gaps through no fault of their own.

No phone support. For a healthcare company charging $199 per month, the absence of a phone support line is unusual. All communication flows through chat and email. When medication supply issues arise, the inability to speak with a person in real time is the source of most BBB complaints.

Insurance dependency. The entire value proposition collapses without insurance coverage for GLP-1 medication. Calibrate cannot control whether your insurer approves the prescription, how long prior authorization takes, or whether your employer plan changes its formulary mid-year. Members caught in insurance limbo pay the program fee while waiting for medication that may never arrive.

The Validation Institute certification has limits. Calibrate's outcomes data was certified by the Validation Institute in March 2024, which adds credibility. However, Validation Institute certification confirms that the data collection methodology is sound, not that the results apply to every enrollee. The 16% and 19% figures represent active, compliant members. Dropout rates, non-response rates, and the percentage of enrollees who never received medication are not included in the certified report.

Post-program weight regain. GLP-1 medications produce weight loss while patients take them. Multiple studies (including the STEP 1 extension trial for semaglutide) show that approximately two-thirds of weight lost is regained within one year of discontinuation. Calibrate's behavioral coaching aims to mitigate this, and their 36-month data suggests some success. But any member who stops both the medication and the coaching should expect weight regain unless they have genuinely internalized the behavioral changes. For strategies when progress stalls, see our guide on not losing weight on semaglutide.